Bibliography

Found 246 results

Filters: Keyword is Female [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

P

Gianella S, Letendre SL, Iudicello J, Franklin D, Gaufin T, Zhang Y, Porrachia M, Vargas-Meneses M, Ellis RJ, Finkelman M, et al. Plasma (1 → 3)-β-D-glucan and suPAR levels correlate with neurocognitive performance in people living with HIV on antiretroviral therapy: a CHARTER analysis. J Neurovirol. 2019 ;25(6):837-843.

Anderson AM, Harezlak J, Bharti A, Mi D, Taylor MJ, Daar ES, Schifitto G, Zhong J, Alger JR, Brown MS, et al. Plasma and Cerebrospinal Fluid Biomarkers Predict Cerebral Injury in HIV-Infected Individuals on Stable Combination Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2015 ;69(1):29-35.

Bryant AK, Moore DJ, Burdo TH, Lakritz JR, Gouaux B, Soontornniyomkij V, Achim CL, Masliah E, Grant I, Levine AJ, et al. Plasma soluble CD163 is associated with postmortem brain pathology in human immunodeficiency virus infection. AIDS. 2017 ;31(7):973-979.

Harezlak J, Cohen R, Gongvatana A, Taylor M, Buchthal S, Schifitto G, Zhong J, Daar ES, Alger JR, Brown M, et al. Predictors of CNS injury as measured by proton magnetic resonance spectroscopy in the setting of chronic HIV infection and CART. J Neurovirol. 2014 ;20(3):294-303.

Malvar J, Vaida F, Sanders CFitzsimons, J Atkinson H, Bohannon W, Keltner J, Robinson-Papp J, Simpson DM, Marra CM, Clifford DB, et al. Predictors of new-onset distal neuropathic pain in HIV-infected individuals in the era of combination antiretroviral therapy. Pain. 2015 ;156(4):731-739.

Anderson AM, Muñoz-Moreno JA, McClernon DR, Ellis RJ, Cookson D, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, et al. Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy. J Infect Dis. 2017 ;215(1):105-113.

Sun B, Fernandes N, Pulliam L. Profile of neuronal exosomes in HIV cognitive impairment exposes sex differences. AIDS. 2019 ;33(11):1683-1692.

Carey C, Woods SPaul, Rippeth JD, Heaton RK, Grant I. Prospective memory in HIV-1 infection. Journal of Clinical and Experimental Neuropsychology [Internet]. 2006 ;28:536-48. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16676475

Guha D, Lorenz DR, Misra V, Chettimada S, Morgello S, Gabuzda D. Proteomic analysis of cerebrospinal fluid extracellular vesicles reveals synaptic injury, inflammation, and stress response markers in HIV patients with cognitive impairment. J Neuroinflammation. 2019 ;16(1):254.

Weiss JJ, Morgello S. Psychiatric management of HIV/HCV-coinfected patients beginning treatment for hepatitis C virus infection: survey of provider practices. General Hospital Psychiatry [Internet]. 2009 ;31:531-537. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19892211

Fellows RP, Spahr NA, Byrd DA, Mindt MRivera, Morgello S. Psychological trauma exposure and co-morbid psychopathologies in HIV+Men and Women. Psychiatry Res. 2015 ;230(3):770-6.

Hobkirk AL, Starosta AJ, De Leo JA, Marra CM, Heaton RK, Earleywine M. Psychometric validation of the BDI-II among HIV-positive CHARTER study participants. Psychol Assess. 2015 ;27(2):457-66.

R

Olsen JP, Fellows RP, Rivera-Mindt M, Morgello S, Byrd DA. Reading Ability as an Estimator of Premorbid Intelligence: Does It Remain Stable Among Ethnically Diverse HIV+ Adults?. Clin Neuropsychol. 2015 ;29(7):1034-52.

Gutierrez J, Byrd D, Yin MT, Morgello S. Relationship Between Brain Arterial Pathology and Neurocognitive Performance Among Individuals With Human Immunodeficiency Virus. Clin Infect Dis. 2019 ;68(3):490-497.

Gutierrez J, Murray J, Chon C, Morgello S. Relationship between brain large artery characteristics and their downstream arterioles. J Neurovirol. 2018 ;24(1):106-112.

Langford D, Marquie-Beck J, de Almeida SM, Lazzaretto D, Letendre S, Grant I, McCutchan JA, Masliah E, Ellis RJ. Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus-infected patients. Journal of Neurovirology [Internet]. 2006 ;12:100-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16798671

Miranda C, Rentería MArce, Fuentes A, Coulehan K, Arentoft A, Byrd D, Rosario A, Monzones J, Morgello S, Mindt MRivera. The Relative Utility of Three English Language Dominance Measures in Predicting the Neuropsychological Performance of HIV+ Bilingual Latino/a Adults. Clin Neuropsychol. 2016 ;30(2):185-200.

Umlauf A, Soontornniyomkij B, Sundermann EE, Gouaux B, Ellis RJ, Levine AJ, Moore DJ, Soontornniyomkij V. Risk of developing cerebral β-amyloid plaques with posttranslational modification among HIV-infected adults. AIDS. 2019 ;33(14):2157-2166.

Thames AD, Briones MS, Magpantay LI, Martinez-Maza O, Singer EJ, Hinkin CH, Morgello S, Gelman BB, Moore DJ, Heizerling K, et al. The role of chemokine C-C motif ligand 2 genotype and cerebrospinal fluid chemokine C-C motif ligand 2 in neurocognition among HIV-infected patients. AIDS. 2015 ;29(12):1483-91.

Letendre SL, Marquie-Beck J, Ellis RJ, Woods SPaul, Best B, Clifford DB, Collier AC, Gelman BB, Marra C, McArthur JC, et al. The role of cohort studies in drug development: clinical evidence of antiviral activity of serotonin reuptake inhibitors and HMG-CoA reductase inhibitors in the central nervous system. J Neuroimmune Pharmacol. 2007 ;2(1):120-7.

Coulehan K, Byrd D, Arentoft A, Monzones J, Fuentes A, Fraser F, Rosario A, Morgello S, Mindt MRivera. The role of decision-making ability in HIV/AIDS: impact on prospective memory. J Clin Exp Neuropsychol. 2014 ;36(7):730-41.

Ances BM, Vaida F, Rosario D, Marquie-Beck J, Ellis RJ, Simpson DM, Clifford DB, McArthur JC, Grant I, J McCutchan A. Role of metabolic syndrome components in HIV-associated sensory neuropathy. AIDS. 2009 ;23(17):2317-22.

McCutchan JA, Marquie-Beck JA, Fitzsimons CA, Letendre SL, Ellis RJ, Heaton RK, Wolfson T, Rosario D, Alexander TJ, Marra C, et al. Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder. Neurology. 2012 ;78(7):485-92.

Yang L, Yao H, Chen X, Cai Y, Callen S, Buch S. Role of Sigma Receptor in Cocaine-Mediated Induction of Glial Fibrillary Acidic Protein: Implications for HAND. Mol Neurobiol. 2016 ;53(2):1329-1342.

Shimizu S, Khan MZ, Hippensteel RL, Parkar A, Raghupathi R, Meucci O. Role of the transcription factor E2F1 in CXCR4-mediated neurotoxicity and HIV neuropathology. Neurobiology of Disease [Internet]. 2007 ;25(1):17-26. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17011204

Pages